 DAVENPORT Co LLC purchased a new position in Bellerophon Therapeutics Inc NASDAQ:BLPH during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 107,150 shares of the biotechnology companys stock, valued at approximately 1,345,000. Other institutional investors have also bought and sold shares of the ... 